The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region

International Journal of Pediatric Otorhinolaryngology

Volumn 72, Issue 5, 2008, Pages 593-597

  Zhi, Keqian ^a   Wen, Yuming ^b   Li, Longjiang ^b   Ren, Wenhao ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Pingyangmycin; Sclerotherapy; Venous malformation

Indexed keywords

BLEOMYCIN A5;

ADOLESCENT; ARTICLE; CHILD; CYTOPENIA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCLEROTHERAPY; SWELLING; THORAX RADIOGRAPHY; VEIN MALFORMATION;

ADOLESCENT; BLEOMYCIN; CHILD; FACE; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MOUTH DISEASES; SCLEROTHERAPY; VASCULAR MALFORMATIONS;

EID: 41149142257     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2008.01.007     Document Type: Article

References (11)

1. Mulliken J.B., and Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast. Reconst. Surg. 69 (1982) 412-422
2. Jackson I.T., Forbes G., and May G.R. Vascular Anomalies (1988), Churchill-Livingstone, London
3. Yura J., Hashimoto T., Tsuruga N., and Shibata K. Bleomycin treatment for cystic hygroma in children. Nippon Geka Hokan 46 (1977) 607-614
4. Herbreteau D., Riche M.C., Enjolras O., Khayata M., Lemarchand-Venencie F., Borsik M., et al. Percutaneous embolization with ethibloc of lymphatic cystic malformation with a review of the experience in 70 patients. Int. Angiol. 12 (1993) 34-39
5. Ogita S., Tsuto T., Tokiwa K., and Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic haygroma in children. Br. J. Surg. 74 (1987) 690-691
6. Buckmiller L.M. Update on hemangiomas and vascular malformations (review). Curr. Opin. Otolaryngol. Head Neck Surg. 12 (2004) 476-487
7. Umezawa H. Recent study on biochemistry and action of bleomycin. In: Carter S.K., Crook S.T., and Umezawa H. (Eds). Bleomycin: Current status and New Development (1978), Academic Press, New York, NY 15-20
8. Tanigawa N., Shimomatsuya T., Takahashi L., et al. Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion. Cancer 60 (1987) 741-749
9. Sung M.W., Chang S.O., Choi J.H., and Kim J.Y. Bleomycin sclerotherapy in patients with congenital and lymphatic malformation in the head and neck. Am. J. Otolaryngol. 16 (1995) 236-241
10. Mathur N.N., Rana I., Bothra R., Dhawan R., Kathuria G., and Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int. J. Pediatr. Otorhinolaryngol. 69 (2005) 75-80
11. Omidvari S., Nezakatgoo N., Ahmadloo N., Mohammadianpanah M., and Mosalaei A.A. Role of intralesional bleomycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol. Surg. 31 (2005) 499-501